"By empowering patients and providers with world class technology, we're helping patients overcome insurance hurdles, drug shortages, and get personalized care to achieve life-changing outcomes." Weight Loss Outcomes According to the outcomes study , the vast majority of patients in the Body membership who received 12 months of treatment with branded semaglutide achieved clinically significant weight loss: 95% lost 5% or more of their body weight 81% lost 10% or more of their body weight 55% lost 15% or more of their body weight 26% lost 20% or more of their body weight These outcomes are consistent with the studied efficacy of GLP-1s, and made possible by pairing the treatment with high-quality, ongoing obesity care via Ro's telehealth platform including: monthly check-ins with providers, 24/7 messaging for care and support, 1-1 coaching, weight tracking and dose logging, labs when appropriate, and side effect monitoring
After 1 min, stop solution was added to terminate the reaction
Was the data encrypted and/or tokenized
While there is not yet an official timeline, Eli Lilly executives have said they plan to submit orforglipron for federal approval by the end of the year
